Jian Xu

发表

Primary Clofazimine and Bedaquiline Resistance among Isolates from Patients with Multidrug-Resistant Tuberculosis

Bin Wang, Minghao Hu, E. Nuermberger, 2017, Antimicrobial Agents and Chemotherapy.

Verapamil Increases the Bioavailability and Efficacy of Bedaquiline but Not Clofazimine in a Murine Model of Tuberculosis

D. Almeida, E. Nuermberger, C. Peloquin, 2017, Antimicrobial Agents and Chemotherapy.

Comparative Efficacy of the Novel Diarylquinoline TBAJ-587 and Bedaquiline against a Resistant Rv0678 Mutant in a Mouse Model of Tuberculosis

N. Fotouhi, P. Converse, K. Mdluli, 2021 .

Comparative Efficacy of the Novel Diarylquinoline TBAJ-587 and Bedaquiline against a Resistant Rv0678 Mutant in a Mouse Model of Tuberculosis

N. Fotouhi, P. Converse, K. Mdluli, 2021, Antimicrobial Agents and Chemotherapy.

Comparative Efficacy of the Novel Diarylquinoline TBAJ-587 and Bedaquiline against a Resistant Rv0678 Mutant in a Mouse Model of Tuberculosis

N. Fotouhi, P. Converse, K. Mdluli, 2020, Antimicrobial Agents and Chemotherapy.

Genetic and Virulence Characteristics of Linezolid and Pretomanid Dual Drug-Resistant Strains Induced from Mycobacterium tuberculosis in vitro

Minghao Hu, Yu Lu, L. Fu, 2020, Infection and drug resistance.

Clofazimine Analogs with Efficacy against Experimental Tuberculosis and Reduced Potential for Accumulation

P. Li, D. Yin, Yu Lu, 2011, Antimicrobial Agents and Chemotherapy.

and Reduced Potential for Accumulation 2

Peng Li, D. Yin, Yu Lu, 2011 .

In Vitro and In Vivo Activities of the Riminophenazine TBI-166 against Mycobacterium tuberculosis

D. Yin, Yu Lu, L. Fu, 2019, Antimicrobial Agents and Chemotherapy.

Shortening Buruli Ulcer Treatment with Combination Therapy Targeting the Respiratory Chain and Exploiting Mycobacterium ulcerans Gene Decay

P. Converse, S. Tyagi, D. Almeida, 2019, Antimicrobial Agents and Chemotherapy.

Oral bioavailability of rifampicin, isoniazid, ethambutol, and pyrazinamide in a 4-drug fixed-dose combination compared with the separate formulations in healthy Chinese male volunteers.

Lin Zhou, Yu Lu, L. Fu, 2013, Clinical therapeutics.

Bedquiline Resistance Mutations: Correlations with Drug Exposures and Impact on the Proteome in M. tuberculosis

E. Nuermberger, Yu Lu, Bin Wang, 2023, Antimicrobial agents and chemotherapy.

Contribution of Pretomanid to Novel Regimens Containing Bedaquiline with either Linezolid or Moxifloxacin and Pyrazinamide in Murine Models of Tuberculosis

N. Fotouhi, P. Converse, K. Mdluli, 2019, Antimicrobial Agents and Chemotherapy.

Comparative Efficacy of the Novel Diarylquinoline TBAJ-587 and Bedaquiline against a Resistant Rv0678 Mutant in a Mouse Model of Tuberculosis

N. Fotouhi, P. Converse, K. Mdluli, 2020, Antimicrobial Agents and Chemotherapy.

In Vitro and In Vivo Activities of the Nitroimidazole TBA-354 against Mycobacterium tuberculosis

J. Xu, Y. Lu, S. Franzblau, 2014, Antimicrobial Agents and Chemotherapy.

Stapled β-Hairpin Antimicrobial Peptides with Improved Stability and Activity against Drug-Resistant Gram-Negative Bacteria

J. Teo, P. L. Ee, Jun-Jie Koh, 2023, Journal of medicinal chemistry.